Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections:A Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: YuanZhuo Chen
- Phone Number: 13764528213
- Email: chenyuanzhuo@tongji.edu.cn
Study Locations
-
-
-
Shanghai, China, 200000
- Recruiting
- Shanghai Tenth Hospital
-
Contact:
- Yuanzhuo Chen, MD
- Email: chenyuanzhuo021@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients diagnosed with severe infections, which is infected patients SAFA≥2 OR APACHE Ⅱ≥15
- Aged ≥14 years
- Patients or their family members agreed to participate in this study
Exclusion Criteria:
- Advanced tumors or diseases associated with systemic immunosuppression
- Pregnant women
- Patients with severe intestinal ulcer or perforation
- Unable to complete oral administration and no effective artificial feeding pipeline.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: The experimental group with FMT
The gastrointestinal tube access was established, and the standard preparation of fecal bacteria solution 20ml (frozen at -80 ° C, melted at room temperature before use) was injected through the gastrointestinal tube once a day for 6 consecutive days.
The other treatment measures were the same as those of the control group
|
The gastrointestinal tube access was established, and the standard preparation of fecal bacteria solution 20ml (frozen at -80 ° C, melted at room temperature before use) was injected through the gastrointestinal tube once a day for 6 consecutive days.
The other treatment measures were the same as those of the control group.
|
|
Other: The control group with physiological saline
The gastrointestinal tube access was established, and the standard preparation of physiological saline solution 20ml
|
physiological saline solution 20ml
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Death
Time Frame: up to 28 days in ICU
|
Clinical outcome
|
up to 28 days in ICU
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gut microbiota distribution assessed by 16SrDNA
Time Frame: up to 6 days after fecal microbial transplantation
|
16SrDNA
|
up to 6 days after fecal microbial transplantation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: YuanZhuo Chen, Shanghai 10th People's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FMT20220925
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.